Drug Shortage Report for RAN-RANITIDINE
Report ID | 85902 |
Drug Identification Number | 02336480 |
Brand name | RAN-RANITIDINE |
Common or Proper name | RAN-RANITIDINE |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-06 |
Estimated end date | Unknown |
Actual end date | 2020-06-22 |
Shortage status | Resolved |
Updated date | 2020-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-08-28 | French | Compare |
v8 | 2020-08-28 | English | Compare |
v7 | 2019-09-23 | French | Compare |
v6 | 2019-09-23 | English | Compare |
v5 | 2019-09-23 | English | Compare |
v4 | 2019-08-19 | French | Compare |
v3 | 2019-08-19 | English | Compare |
v2 | 2019-06-07 | French | Compare |
v1 | 2019-06-07 | English | Compare |
Showing 1 to 9 of 9